Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus

Journal of Clinical Pathology

Volumn 51, Issue 2, 1998, Pages 149-153

  Van Deursen, F J ^a   Hino, K ^a   Wyatt, D ^b   Molyneaux, P ^c   Yates, P ^d   Wallace, L A ^a   Dow, B C ^e   Carman, W F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d Aberdeen N E Scotland Blood T   (United Kingdom)

^e SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Genetic variation; Hepatitis B; Polymerase chain reaction

Indexed keywords

AMINO ACID; ARGININE; GLYCINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; EVOLUTION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME; HEPATITIS B VIRUS; HUMAN; LABORATORY DIAGNOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; VIREMIA; VIRUS INFECTION;

EID: 0031887885     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.2.149     Document Type: Article

References (22)

1. Carman WF, Thomas HC, Domingo E. Viral genetic variation; hepatitis B virus as a clinical example. Lancet 1993;334:349-53.
2. Blum HE. Hepatitis B virus: significance of naturally occurring mutants. Intervirology 1993;35:40-50.
3. Wallace LA, Carman WF. Surface gene variation of HBV: scientific and medical relevance. Vir Hep Revs 1997;3:5-16.
4. Bollyky PL, Yasmin M, Holmes EC, et al. Viruses from unrelated fulminant hepatitis B cases cluster in phylogenetically distinct lineages, each containing unique motifs of nucleotide and HBx variants which have increased transcription activity in vitro [abstract]. J Hepatol 1997; 26(suppl 1):67.
5. Baumert TF, Rogers SA, Hasegawa K, et al. Two core promotor mutations identified on a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996;98:2268-76.
6. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
7. Hawkins A, Gilson R, Gilbert N, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996;24:8-14.
8. Fujii H, Moriyama K, Sakamoto N, et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992;184: 1152-7.
9. Hino K, Okuda M, Hashimoto O, et al. Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig Dis Sci 1995;40: 566-70.
10. Okamoto H, Yano K, Nozaki Y, et al. Mutations within the s gene of hepatitis-B virus transmitted from mothers to babies immunized with hepatitis-B immune globulin and vaccine. Pediatr Res 1992;32:264-8.
11. McMahon G, Ehrlich PH, Moustafa AZ, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992;15:757-66
12. Carman WF, Korula J, Wallace L, et al. Fulminant reactivation of hepatitis B due to envelope protein mutant of HBV that escaped detection by monoclonal HBsAg ELISA. Lancet 1995;345:1406-7.
13. Yamamoto K, Horita M, Tsuda F, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994;68:2671-6.
14. Waters J, Kennedy M, Voet P, et al. Loss of the common "a" determinant of hepatitis B surface antigen by a vaccine induced escape mutant. J Clin Invest 1992;90:2543-7.
15. Hou JL, Karayiannis P, Thomas HC, et al. A unique insertion in the S gene of surface antigen negative HBV in Chinese carriers. Hepatology 1995;21:273-8.
16. Peterson DL, Paul DA, Lam J, et al. Antigenic structure of hepatitis B surface antigen: identification of the d subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol 1984;132:920-7.
17. Chen Y-CJ, Delbrook K, Dealwis C, et al. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci USA 1996;93:1997-2001.
18. Carman WF, van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa and Sardinia. Hepatology 1997;26:1658-67.
19. Ling R, Mutimer DJ, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996;24:711-13.
20. Kloster B, Kramer R, Easthund T, et al. Hepatitis B surface antigenaemia in blood donors following vaccination. Transfusion 1995;35:475-7.
21. 2-like infections. J Med Virol 1995;46:375-9.
22. Feitelson MA, Duon L-X, Guo J, et al. Precore and X region mutants in hepatitis B virus infections among renal dialysis patients. J Viral Hep 1995;2:19-31.